CHAIR
:
PRESENTER
(S):
Kendra Martello, Assistant General Counsel, PhRMA
John Lewis,
Association of Clinical Research Organizations, United States
Executive Director of the Coalition for Healthcare Communication, a drug-marketing group with offices in New York City and Washington, DC. He is also of counsel with the law firm Wiley Rein LLP, and is a well-known advocate for First Amendment rights of individuals and corporations.
|
Formerly head of Hematology Oncology at MGH and Co-Director of Hematology at Brigham & Women’s Hospital (BWH), Dr. Stossel is currently Director of Translational Medicine and the Center for Medical Innovation at BWH and American Cancer Society Professor at Harvard.
|
Daniel Carlat, Pew Prescription Project, United States
Sandra Dennis, Biotechnology Industry Organization (BIO), United States
Description
This controversial provision of the Affordable Care Act has its proponents and its critics, but, as it goes into effect, this panel will focus on its likely impact on the public health and all the stakeholders — government, lawyers and accountants, the pharmaceutical and medical device industries, researchers and investigators, physicians, and others. The panelists, representing a cross-section of interest areas, will take a look at the burdens and benefits, the potential impact on clinical research, the advantages offered by the resultant transparency and how all of this will play out with the public and organized medicine.
Learning Objectives:
Discuss the Physician Payment Act and its likely impact on the public health and all stakeholders.